FBLG (FibroBiologics) Non Operating Income : $-5.45 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. FibroBiologics's Non Operating Income for the three months ended in Sep. 2024 was $2.78 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was $-5.45 Mil.

FibroBiologics Non Operating Income Historical Data

The historical data trend for FibroBiologics's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Non Operating Income Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Non Operating Income

-7.45

FibroBiologics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Non Operating Income	Get a 7-Day Free Trial						-0.14	-7.24	-5.05	4.06	2.78

FibroBiologics Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.45 Mil.

FibroBiologics Non Operating Income Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.